Add BrightSurf on Google Email

Science News for March 12, 2023


HKUMed develops a nanoparticle-based targeted drug delivery system for treatment of obesity and atherosclerosis

A research team from HKUMed developed thyroid hormone (TH)-encapsulated nanoparticles that selectively target adipose tissues, reducing obesity-related metabolic complications and atherosclerosis. The treatment converts 'bad' white fat to 'good' brown fat, burning calories and alleviating hypercholesterolemia.

SourceThe University of Hong Kong·JournalNature Communications·TypeExperimental study·DateMar 12, 2023

Mending broken hearts using bio-printed ‘patches’

Researchers at University of Technology Sydney have successfully created personalized 'bio-inks' from patients' own stem cells, which are then used to 3D-print cardiac tissues to repair areas of dead tissue. This technology shows promise in treating heart failure and may reduce the need for expensive and traumatic heart transplants.

SourceUniversity of Technology Sydney·JournalBioprinting·TypeExperimental study·DateMar 12, 2023

New drug to lower brain pressure could treat blinding IIH headaches, trial finds

A phase two trial found that exenatide significantly reduced brain pressure and monthly headaches in seven patients with Idiopathic Intercranial Hypertension (IIH). The study showed a rapid action of the drug, with results indicating significant reductions in brain pressure and headache days compared to the placebo arm.

SourceUniversity of Birmingham·JournalBrain·TypeRandomized controlled/clinical trial·DateMar 12, 2023